Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Jun;62(6):2375–2378. doi: 10.1128/iai.62.6.2375-2378.1994

Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin.

M A Couto 1, L Liu 1, R I Lehrer 1, T Ganz 1
PMCID: PMC186521  PMID: 8188361

Abstract

Although purified defensins are effective microbicides in vitro, their operation within intact phagocytes has not been established. To address this question, we inserted cDNA encoding human defensin HNP-1 into a pBabe/neo retroviral vector and transduced it into RAW 264.7 cells, a murine macrophage line that lacks endogenous defensins. We isolated five independent clones of HNP-1-transduced cells, all of which secreted prodefensin and contained small amounts of fully processed HNP-1. The two clones that produced the largest amounts of defensin (clones 5 and 14), together with wild-type RAW cells and pBabe/neo-transduced RAW cells (control), were used for the present study. All cells were grown in Dulbecco's modified Eagle's medium-F12 medium that contained 10% heat-inactivated fetal bovine serum and gentamicin. The medium used for the transduced cells contained aminoglycoside G418 in lieu of gentamicin. Both wild-type and transduced cells were placed in antibiotic-free medium 96 h prior to challenge with a yeast-phase strain of Histoplasma capsulatum. Phagocytosis of yeast cells was allowed to proceed for 90 min and was followed by washing and further incubation for 18.5 h. Whereas the phagocytic index did not differ significantly among the four cell populations under study, the mean level of intracellular growth of H. capsulatum in the defensin-transduced RAW cells was significantly lower than those observed for any other cell types (P < 0.05). These findings constitute the first instance of xenogeneic expression of an antimicrobial peptide by phagocytes and suggest that macrophages can be armed with defensins to enhance their ability to restrict certain intracellular pathogens.

Full text

PDF
2375

Images in this article

2377Image
on p.2377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Couto M. A., Harwig S. S., Cullor J. S., Hughes J. P., Lehrer R. I. Identification of eNAP-1, an antimicrobial peptide from equine neutrophils. Infect Immun. 1992 Aug;60(8):3065–3071. doi: 10.1128/iai.60.8.3065-3071.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Eisenhauer P. B., Lehrer R. I. Mouse neutrophils lack defensins. Infect Immun. 1992 Aug;60(8):3446–3447. doi: 10.1128/iai.60.8.3446-3447.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun. 1987 Mar;55(3):568–571. doi: 10.1128/iai.55.3.568-571.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ganz T., Liu L., Valore E. V., Oren A. Posttranslational processing and targeting of transgenic human defensin in murine granulocyte, macrophage, fibroblast, and pituitary adenoma cell lines. Blood. 1993 Jul 15;82(2):641–650. [PubMed] [Google Scholar]
  5. Ganz T., Selsted M. E., Szklarek D., Harwig S. S., Daher K., Bainton D. F., Lehrer R. I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985 Oct;76(4):1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lehrer R. I., Lichtenstein A. K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol. 1993;11:105–128. doi: 10.1146/annurev.iy.11.040193.000541. [DOI] [PubMed] [Google Scholar]
  7. Lehrer R. I., Szklarek D., Selsted M. E., Fleischmann J. Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant. Infect Immun. 1981 Sep;33(3):775–778. doi: 10.1128/iai.33.3.775-778.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morgenstern J. P., Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 1990 Jun 25;18(12):3587–3596. doi: 10.1093/nar/18.12.3587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Panyutich A. V., Voitenok N. N., Lehrer R. I., Ganz T. An enzyme immunoassay for human defensins. J Immunol Methods. 1991 Aug 9;141(2):149–155. doi: 10.1016/0022-1759(91)90141-2. [DOI] [PubMed] [Google Scholar]
  10. Valore E. V., Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood. 1992 Mar 15;79(6):1538–1544. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES